Latest Employee Incentives News

ReadCloud announces CEO Andrew Skelton’s departure after three years of operational overhaul and financial turnaround, appointing CFO Luke Murphy as interim CEO amid strong growth momentum.

Amaero Ltd has sent out its Scheme Booklet for the upcoming June 5, 2026 meetings where shareholders will vote on the company’s re-domiciliation to the US and approve new incentive options.

Amaero Ltd is set to re-domicile from Australia to Delaware via court-approved schemes, issuing US HoldCo CHESS Depositary Interests to shareholders while maintaining its ASX listing. The move aims to tap into deeper US capital markets and enhance strategic growth opportunities.

True North Copper (ASX:TNC) reported robust drilling results confirming the high-grade Aquila discovery at Mt Oxide, a 7% resource increase at Cloncurry, and a strategic JV acquisition with Glencore, setting the stage for a pivotal 2026.

Rakon Limited has swung back to profit in FY26, reporting a 24% revenue lift and doubling EBITDA, while Bourns' takeover offer edges closer to completion with 85% shareholder acceptance and pending French regulatory approval.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Great Southern Mining (ASX:GSN) reported a substantial extension of gold mineralisation at its Golden Boulder discovery in Western Australia, alongside the commencement of deep diamond drilling co-funded by the WA Government. The company also raised A$4.2 million to fuel ongoing exploration.

EOS management, including CEO Dr Andreas Schwer and CFO Clive Cuthell, have exercised over 3.3 million share options, with the CEO set to sell a significant portion to fund personal commitments.

Aurora Energy Metals has appointed seasoned geologist Aidan Platel as Managing Director and CEO, alongside Warren Hallam as Non-Executive Chair, marking a strategic leadership transition after divesting its uranium project.

ReNerve Limited reported a half-year loss of $2.72 million, up 47% from last year, as it expands its nerve repair product portfolio and secures new regulatory approvals in Asia-Pacific.

Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.

Academies Australasia Group reported a 21% reduction in net loss for the half year to December 2025, alongside a strategic share buy-back and increased director lending. Despite a 6% revenue dip, EBITDA remained steady, signalling cautious operational resilience.